Experienced Protocol Writing

As chairman of the APS and IASP clinical trial special interest groups, our chief scientific officer, Dr. Neil Singla, understands that certain protocol design elements predict success while others predict failure. He has published extensively in the field of analgesic methodology and placebo response mitigation. The knowledge he has garnered from these scientific pursuits allows Lotus to offer trial sponsors expert and customized analgesic consulting services—a benefit that is part and parcel of all our CRO offerings.